Status:
COMPLETED
Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Duchenne Muscular Dystrophy (DMD)
Eligibility:
All Genders
3-5 years
Brief Summary
To perform the reliability and validity study of the Peabody Developmental Motor Scale (Peabody Developmental Motor Scales-2) in children with Duchenne Muscular Dystrophy (DMD).
Eligibility Criteria
Inclusion
- for Group I:
- No neurodevelopmental problems or diseases
- 3-5 years old
- Being able to cooperate with the instructions given by the physiotherapist.
- Children who volunteered to participate in the study and whose families gave consent form will be included in the study.
- for Group II:
- Being diagnosed with Duchenne Muscular Dystrophy by a pediatric neurologist
- 3-5 years old
- Children who volunteered to participate in the study and whose parents' consent was obtained will be included in the study.
Exclusion
- Children with a behavioral condition and any disorder that interferes with testing (eg autism spectrum disorder)
- Failure to cooperate with the physiotherapist who made the evaluations.
- Lack of volunteers.
Key Trial Info
Start Date :
July 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05990608
Start Date
July 30 2021
End Date
July 30 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ondokuz Mayıs University
Samsun, Turkey (Türkiye), 55270